Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Lilly’s breast cancer drug abemaciclib shows promising results in phase 3 trial Indianapolis-based pharmaceutical giant Lilly has announced positive outcomes from its phase 3 clinical trial, MONARCH 2, involving its… bypharmanewsdailyMarch 22, 2017